141 related articles for article (PubMed ID: 1943983)
1. [Sulbactam in combination with mezlocillin, piperacillin or cefotaxime. Clinical and bacteriological results in the treatment of severe bacterial infections].
Manncke K; Springsklee M; Heizmann WR; Sonntag HG
Med Klin (Munich); 1991 Sep; 86(9):454-60. PubMed ID: 1943983
[TBL] [Abstract][Full Text] [Related]
2. Sulbactam in combination with mezlocillin, piperacillin or cefotaxime: clinical and bacteriological findings in the treatment of serious bacterial infections.
Manncke K; Springsklee M; Heizmann WR; Sonntag HG
Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S47-54. PubMed ID: 18611720
[TBL] [Abstract][Full Text] [Related]
3. Sulbactam/ampicillin combination in the treatment of acute and chronic lower respiratory infections.
Bisetti A; Grassi L; Scacciacillani E; Putti P
J Int Med Res; 1991; 19 Suppl 1():36A-43A. PubMed ID: 2060692
[TBL] [Abstract][Full Text] [Related]
4. [Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients].
Lode H; Springsklee M
Med Klin (Munich); 1989 May; 84(5):236-41. PubMed ID: 2661984
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
Schmalreck AF; Wildfeuer A
Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
[TBL] [Abstract][Full Text] [Related]
6. [An open comparative study of sulbactam/ampicillin vs mezlocillin in adult and pediatric patients. Efficacy and tolerability].
Chiodo F; Manfredi R; Zucchini A
Minerva Med; 1991 Jun; 82(6):387-94. PubMed ID: 2067712
[TBL] [Abstract][Full Text] [Related]
7. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
Jauregui L; Minns P; Hageage G
Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
[TBL] [Abstract][Full Text] [Related]
8. [The effect of sulbactam on the in vitro activity of mezlocillin, piperacillin and cefotaxime].
Bauernfeind A; Grimm H; Klietmann W; Opferkuch W; Werner H
Arzneimittelforschung; 1991 Aug; 41(8):831-8. PubMed ID: 1781806
[TBL] [Abstract][Full Text] [Related]
9. Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination.
Wildfeuer A; Schmalreck A; Räder K; Eibel G; Pfaff G
Arzneimittelforschung; 1989 Jan; 39(1):94-100. PubMed ID: 2785802
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
11. Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse.
Talan DA; Summanen PH; Finegold SM
Clin Infect Dis; 2000 Aug; 31(2):464-71. PubMed ID: 10987706
[TBL] [Abstract][Full Text] [Related]
12. [Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)].
Wagenlehner E; Niemetz A; Naber G
Urologe A; 2003 Jan; 42(1):13-25. PubMed ID: 12574879
[TBL] [Abstract][Full Text] [Related]
13. [Sulbactam/ampicillin in comparison with cefuroxime for infections of the lower respiratory tract. Results of a prospective, randomized comparative study].
Schwigon CD; Cuhorst R; Gabor M; Zinndorf J; Springsklee M
Med Klin (Munich); 1993 Jan; 88(1):16-20. PubMed ID: 8437527
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
File TM; Tan JS
Eur J Surg Suppl; 1994; (573):51-5. PubMed ID: 7524796
[TBL] [Abstract][Full Text] [Related]
15. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of sulbactam plus ampicillin in the treatment of general pediatric infections.
Bassetti D; Solbiati M; Ravelli A; Martini A; Viola S; Burgio RG
APMIS Suppl; 1989; 5():41-4. PubMed ID: 2660870
[TBL] [Abstract][Full Text] [Related]
17. [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
Abs L; Kattan J; Culine S; Bekradda M; Farhat F; Droz JP
Bull Cancer; 1994 Oct; 81(10):871-6. PubMed ID: 7734770
[TBL] [Abstract][Full Text] [Related]
18. Sultamicillin experiences in the field of internal medicine.
Hara K; Kobayashi H
APMIS Suppl; 1989; 5():51-6. PubMed ID: 2660872
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of oral fleroxacin and amoxicillin/clavulanate potassium in skin and soft tissue infections.
Tassler H
Am J Med; 1993 Mar; 94(3A):159S-165S. PubMed ID: 8452174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
